Geode Capital Management

Geode Capital Management is a systematic asset management firm headquartered in Boston, Massachusetts, that operates independently of the life sciences sector. Originally established in 2001 as a quantitative investment unit within Fidelity Investments, it was spun off in 2003 and now manages over $1 trillion in assets. The firm specializes in index-based strategies and quantitative equity management, serving as the primary sub-advisor for Fidelity’s index fund lineup. While Geode may hold significant positions in healthcare and biotech stocks through its passive and systematic portfolios, it does not engage in drug discovery, clinical development, or healthcare service provision. Its business model is centered on financial technology and data-driven investment execution rather than biological research.